Medical Affairs and Clinical Operations

The Medical Affairs and Clinical Operations team at Intercept Pharmaceuticals is responsible for overseeing the development and execution of clinical research programs aimed at evaluating the efficacy and safety of novel treatments for chronic liver diseases. This team collaborates across various functions, including regulatory science, medical writing, pharmacovigilance, and field medical liaison activities, to ensure the successful delivery of clinical trials and the dissemination of scientific information to healthcare professionals. Their efforts support the company's mission to bring innovative therapies like obeticholic acid to market, improving patient outcomes in liver disease management.